Concepedia

Parita Shah

PS

Statistics

Publications

19

Citations

977

H-Index

14

Active since

1991

Affiliations

Centre for Addiction and Mental Health(Current)

University of Toronto

Keio University

Mental Health Research Canada

Toronto General Hospital

Parita Shah is an author at Centre for Addiction and Mental Health specializing in medicine, pharmacology, and medicinal chemistry.

ORCID

Publications per year

1991–2022

19

Publications

19

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

James L. Alexander, Nicholas A. Kennedy, Hajir Ibraheim et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 149 citations · Full text

, , +17

Insight and medication adherence in schizophrenia: An analysis of the CATIE trial

Julia Kim, Miracle Ozzoude, Shinichiro Nakajima et al. · Neuropharmacology · 2019 · 136 citations

, , +14

Glutamatergic Neurometabolite Levels in Patients With Ultra-Treatment-Resistant Schizophrenia: A Cross-Sectional 3T Proton Magnetic Resonance Spectroscopy Study

Yusuke Iwata, Shinichiro Nakajima, Eric Plitman et al. · Biological Psychiatry · 2018 · 123 citations

, , +17

Sertraline response in adults with mental retardation and autistic disorder.

Jessica A. Hellings, Lee Ann Kelley, William F. Gabrielli et al. · PubMed · 1996 · 111 citations

, , +14

COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study

James L. Alexander, Zhigang Liu, Diana Mūnoz Sandoval et al. · ˜The œLancet. Gastroenterology & hepatology · 2022 · 67 citations · Full text

, , +17

1–5 of 19